ERNA

Ernexa Therapeutics Inc.

Healthcare · Biotechnology

$158.26 sample

-1.58 (-0.99%) 1D

Market cap

$842.0B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-09

Alerts

8

Price$158.26 -1.25% 3M daily closessample

168.34158.26

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider buy: EVP, Operations
Oct 01INSInsider sell: EVP, Operations
Sep 22INSInsider sell: 10% owner
Sep 16INSInsider sell: 10% owner
Sep 09SECDEF 14A filed
Sep 01INSInsider sell: 10% owner
Aug 25SECDEF 14A filed
Aug 17INSInsider buy: General Counsel

Sign up to see the real ERNA record →

Company facts

SEC EDGAR registration

Name: Ernexa Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -16sample, -100 to +100
Reporting currency: USD

Who is positioning in ERNA

sample

Insiders: 29 insider transactions over 90 days, net selling, $111.2M
Congress: 1 members traded over 90 days
Institutions · 13F: 6 funds hold $16.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$41.9B +21.3% y/y

Q4 2024Q3 2026

Inventory$24.8B +19.4% y/y

Q4 2024Q3 2026

Accounts receivable$18.3B +7.9% y/y

Q4 2024Q3 2026

Total debt$50.4B +12.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $610.6B +5.7% 3M
Sample peer B: $503.3B -5.9% 3M
Sample peer C: $178.2B +4.4% 3M
Sample peer D: $502.0B -5.4% 3M
Sample peer E: $829.7B +12.3% 3M